CNXU on Nasdaq

Conexeu Sciences Inc.

Conexeu Sciences Inc. is an American orthopedic company that raised $7.7 million in 2026 (SEC Form D).1 It is headquartered in Reno, Nevada.1 Its shares trade on Nasdaq under the symbol CNXU.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCNXU on Nasdaq1
  • IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
  • HeadquartersReno, Nevada1
  • Incorporated inNV2
  • Business address50 West Liberty Street, Suite 880, Reno, Nv 895012
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2
  • Legal formCorporation

Corporate structure

Conexeu Sciences Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Conexeu Sciences Inc.

  • Conexeu Sciences Inc. Reno, Nevada

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led Conexeu Sciences Inc., and when. Pick a name to see everywhere that person has worked.

Chief financial officer

  1. Stephen Douglas Inouye2026–now
Board members and other officers (10)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorMILES R HARRISON named Nov 13, 2025 to Sep 29, 202614
  • DirectorJEFF D SHARPE named Jul 2, 2025 to Sep 29, 202614
  • DirectorSEBASTIAN PAUL PURCELL named Nov 13, 2025 to Sep 29, 202614
  • DirectorZ PAUL LORENC named Jul 2, 2025 to Sep 29, 202614
  • DirectorMICHAEL R WRIGHT named Jul 2, 202515

Timeline

  1. Sep 10, 20268-K Unregistered sale of shares16
  2. Jul 7, 20268-K Regulation FD disclosure17
  3. Jun 9, 20268-K Unregistered sale of shares18
  4. May 15, 20268-K Unregistered sale of shares; Bylaws or fiscal year changed19

Filings

82 filings to the SEC since October 2021: 2 quarterly reports, 4 major events, 26 insider forms, 10 large holders, 19 private raises, 21 other. The latest 20:

  1. Sep 29, 2026D EDGAR
  2. Sep 28, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  3. Sep 15, 2026D EDGAR
  4. Sep 15, 2026SCHEDULE 13D/A EDGAR
  5. Sep 15, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  6. Sep 15, 2026424B3 EDGAR
  7. Sep 14, 202610-Q EDGAR
  8. Sep 10, 2026424B3 EDGAR
  9. Sep 10, 20268-K EDGAR
  10. Sep 9, 20264/A PRIMARY DOCUMENT EDGAR
  11. Sep 9, 20264 PRIMARY DOCUMENT EDGAR
  12. Sep 4, 2026SCHEDULE 13G/A EDGAR
  13. Sep 4, 2026SCHEDULE 13G EDGAR
  14. Aug 31, 2026D EDGAR
  15. Aug 18, 2026SCHEDULE 13D EDGAR
  16. Aug 18, 2026SCHEDULE 13G EDGAR
  17. Aug 14, 2026SCHEDULE 13G EDGAR
  18. Aug 14, 2026SCHEDULE 13G EDGAR
  19. Aug 14, 2026SCHEDULE 13G EDGAR
  20. Jul 31, 2026D EDGAR

The 82 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 18, 2026Purcell Lynn SebastianDirectorBuy202,500$0.80$162.0KForm 4
May 12, 2026Purcell Lynn SebastianDirectorBuy422,500$0.80$338.0KForm 4
May 12, 2026OnePointTwo Capital Ventures LLC10% ownerBuy422,500$0.80$338.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 23, 2026Raised $30,875 in a private offering of equity Form D: 2 investors so far Form D
  2. Sep 1, 2026Raised $252,148 in a private offering of equity Form D: 2 investors so far Form D
  3. Aug 24, 2026Raised $88,548 in a private offering of equity Form D: 3 investors so far Form D
  4. Jul 23, 2026Raised $62,725 in a private offering of equity Form D: 2 investors so far Form D
  5. Jun 22, 2026Raised $86,320 in a private offering of equity Form D: 2 investors so far Form D
  6. Jun 18, 2026Raised $203 in a private offering of securities Form D: $465,953 offered in all Form D
  7. May 28, 2026Raised $22,905 in a private offering of equity Form D: $137,427 offered in all Form D
  8. May 14, 2026Raised $44,700 in a private offering of equity Form D: 1 investor so far Form D
  9. May 12, 2026Raised $543 in a private offering of securities Form D: $1.2 million offered in all Form D
  10. Mar 25, 2026Raised $1.8 million in a private offering of equity Form D: 8 investors so far Form D
  11. Mar 16, 2026Raised $44,698 in a private offering of equity Form D: 1 investor so far Form D
  12. Feb 11, 2026Raised $467 in a private offering of securities Form D: $1.1 million offered in all Form D
  13. Jan 26, 2026Raised $810,000 in a private offering of equity Form D: 1 investor so far Form D
  14. Nov 14, 2025Raised $202,299 in a private offering of equity Form D: 7 investors so far Form D
  15. Oct 28, 2025Raised $2.9 million in a private offering of equity Form D: 5 investors so far Form D
  16. Jun 5, 2025Raised $1,700 in a private offering of equity Form D: $2,200 offered in all Form D
  17. Apr 10, 2025Raised $1.3 million in a private offering of equity Form D: $2.5 million offered in all Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
UBS Group AG12,264$133.9K0.0%New
Morgan Stanley5,871$64.1K0.0%New
Citigroup Inc5,219$57.0K0.0%New
Hollencrest Capital Management1,000$10.9K0.0%New
Royal Bank Of Canada887$10.0K0.0%New
Integrated Wealth Concepts LLC400$4.4K0.0%New
Jones Financial Companies Lllp100$1.1K0.0%New
Osaic Holdings, Inc.100$1.1K0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Conexeu Sciences Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARConexeu Sciences Inc.1
  • CIK0002066836
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inNevada1
  • Fiscal year endsOctober 311
  • Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address50 West Liberty Street, Suite 880, Reno, NV 895011
  • Phone604-315-47221
  • Shares outstanding28,206,698 as of Sep 10, 202628
  • On EDGAR sinceMay 9, 20251
  • Filings82 in all: D (17), 3 (15), 4 (10), SCHEDULE 13G (7), S-1/A (6), 424B3 (5), 8-K (4), 10-Q (2)1
    All 22 form types

    C-U (2), D/A (2), 4/A (1), 424B4 (1), 8-A12B (1), C (1), C-AR (1), C/A (1), CERT (1), EFFECT (1), S-1 (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1), SCHEDULE 13G/A (1)

  • Latest filingsQuarterly report (10-Q) Sep 14, 2026
    Latest 8-K (8-K) Sep 10, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28